5 Results for "

Matrigel invasion

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "Matrigel invasion" in MCE Product Catalog:

3
3 Cited Publications
Cat. No.: HY-103444
CAS No.: 704888-90-4
Purity:  98.07%
Target:  

MMP

Research Areas:  

Cancer

ARP-100 is a potent and selective matrix metalloproteinase MMP-2 inhibitor (IC50=12 nM). ARP-100 interacts with S1' pocket of MMP-2 and shows anti-invasive properties in an in vitro model of invasion on matrigel. ARP-100 shows the less inhibitory activity towards MMP-1 (>50 μM), MMP-3 (4.5 μM), MMP-7 (>50 μM), and MMP-9 (0.2 μM) .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-15478
CAS No.: 55778-02-4
Purity:  99.80%
Target:  

MOFs CXCR

Research Areas:  

Endocrinology Cancer

WZ811 is an orally active, highly potent competitive antagonist of CXCR4. WZ811 efficiently inhibits CXCR4/SDF-1 (or CXCL12)-mediated modulation of cAMP levels (EC50=1.2 nM) and SDF-1 induced Matrigel invasion in cells (EC50=5.2 nM) .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-149394
CAS No.: 2996096-63-8
Purity:  98.04%
Research Areas:  

Cancer

PRDX1-IN-1 is a selective inhibtor of PRDX1 with an IC50 value of 0.164 μM. PRDX1-IN-1 can be used in researches related to cancer.PRDX1-IN-1 promots intracellular ROS accumulation, and inhibits the proliferation, invasion and migration of cancer cells besides inducing apoptosis. PRDX1-IN-1 could be used in cancer research .
loading...
    loading...
Cat. No.: HY-103444R
CAS No.: 704888-90-4
Target:  

Reference Standards MMP

Research Areas:  

Cancer

ARP-100 (Standard) is the analytical standard of ARP-100. This product is intended for research and analytical applications. ARP-100 is a potent and selective matrix metalloproteinase MMP-2 inhibitor (IC50=12 nM). ARP-100 interacts with S1' pocket of MMP-2 and shows anti-invasive properties in an in vitro model of invasion on matrigel. ARP-100 shows the less inhibitory activity towards MMP-1 (>50 μM), MMP-3 (4.5 μM), MMP-7 (>50 μM), and MMP-9 (0.2 μM) .
loading...
    loading...
Cat. No.: HY-184734
Target:  

STAT NF-κB

Research Areas:  

Cancer

STAT3/NF-κB-IN-2 is a dual STAT3/NF-κB inhibitor that exhibits antiproliferative, antimigratory and anti-invasive activities in cancer cells. STAT3/NF-κB-IN-2 inhibits the transcriptional activities of NF-κB and STAT3, binds to the STAT3-SH2 domain, and blocks STAT3 dimerization. STAT3/NF-κB-IN-2 can be used in studies related to triple-negative breast cancer .
loading...
    loading...